Charles River Labs (CRL) PT Raised to $128 at Barclays
Barclays analyst Jack Meehan raised the price target on Charles River Labs (NYSE: CRL) to $128.00 (from $120.00) while maintaining a Equalweight rating.
Barclays analyst Jack Meehan raised the price target on Charles River Labs (NYSE: CRL) to $128.00 (from $120.00) while maintaining a Equalweight rating.